- Home
- CRBU vs CHEC Comparison
CRBU vs CHEC Comparison
Compare CRBU & CHEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRBU | CHEC |
|---|---|---|
| Founded | 2011 | 2024 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 203.9M | 173.4M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | CRBU | CHEC |
|---|---|---|
| Price | $1.76 | $10.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $10.75 | N/A |
| AVG Volume (30 Days) | ★ 983.6K | 35.0K |
| Earning Date | 03-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.64 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.63 | N/A |
| Revenue Next Year | $10.93 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.66 | $9.91 |
| 52 Week High | $3.53 | $10.56 |
Technical Indicators
Market Signals| Indicator | CRBU | CHEC |
|---|---|---|
| Relative Strength Index (RSI) | 45.36 | 51.70 |
| Support Level | $1.70 | $10.02 |
| Resistance Level | $2.04 | $10.07 |
| Average True Range (ATR) | 0.11 | 0.01 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 3.70 | 40.59 |
Price Performance
Historical ComparisonAbout CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.
About CHEC Chenghe Acquisition III Co. Class A Ordinary Share
Chenghe Acquisition III Co is blank check company.